Economic evaluation of a trial exploring the effects of a web-based support tool for parents of children with juvenile idiopathic arthritis
Authors' conclusion
The WebParC intervention led to reductions in primary and secondary healthcare resource use and costs at 4 and 12 months.
Study context
- Population
- Parents of children with JIA, paediatric rheumatology centres in England
- Participants
- 220 parents
- Comparison
- WebParC web-based support tool vs control
- Primary endpoint
- Illness-related parenting stress (self-report Pediatric Inventory for Parents), dimensions difficulty and frequency
- Follow-up
- 4 and 12 months
Methodological detailsmulticentre, cost-effectiveness analysis, UK NHS perspective, bootstrapping and cost-effectiveness acceptability curves
- Multicentre
- Cost-effectiveness analysis
- UK NHS perspective
- Bootstrapping and cost-effectiveness acceptability curves
Primary result
As reported in the abstract
PIP score improvement, intervention arm · 4 months
Improved average PIP frequency score, intervention arm
1.5
Improved average PIP difficulty score, intervention arm
3.6
Further findings
| Outcome | Mean difference (£) (95% CI) | |
|---|---|---|
| Average total cost per case (higher in control) · 4 months | 360 (£29.6 to £691) | |
| Average total cost per case (higher in control) · 12 months | 203 (£16 to £390) | |
| −50005001000Difference, £ (linear scale) |
PIP score improvement, intervention arm · 12 months
- Improved average PIP frequency score, intervention arm
- 0.35
- Improved average PIP difficulty score, intervention arm
- 0.39
Probability of intervention being cost-effective
- Probability cost-effective
- 49% and 54%
- Ranged between 49% and 54%
Original publication
Economic evaluation of a trial exploring the effects of a web-based support tool for parents of children with juvenile idiopathic arthritis. Rheumatology (Oxford). Published 22 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →